B. Riley Securities Initiates Coverage On Praxis Precision Medicine with Buy Rating, Announces Price Target of $713
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsInitiationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
B. Riley Securities analyst Madison El-Saadi initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $713.
B. Riley Securities analyst Madison El-Saadi initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $713.
